• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Marsing to market products of 6 Indian Pharma Cos in Europe

      Bangalore: Denmark-based Pharmaceutical marketing and distributing company, Marsing, will take up marketing of products of six major Indian Pharma Companies in Europe, besides Hikal, which had a majority stake in it.

      Marsing Chairman Jai Hiremath, also the Vice-Chairman and Managing Director of Hikal Ltd, told newspersons here that Marsing had made good progress in getting regulatory approvals for Hikal's Active Pharmaceutical Ingredients (APIs) in Europe and was in advanced discussions with other Indian Pharmaceutical companies to distribute their APIs, hospital injectables and veterinary formulations in the European market.

      Hikal had also recently acquired a minority stake in the subsidiary of 28 billion Dollar Sinochem, a Chinese pharma major.

      Marsing would not only have direct marketing of products from Sinochem in Europe, but also sell products routed through Hikal by Sinochem.

      Hikal had in September 2004 acquired 50.1 per cent shareholding in Marsing for a consideration of six million Dollars. The acquisition was partly funded by internal accruals and partly by the Exim Bank. However, Hikal had settled the Exim Bank loan through a Foreign Currency Convertible Bond issue, under which the company had diluted its stake to 68 per cent from 75 per cent, Mr Hiremath said.

      Marsing also had a 100 per cent French subsidiary Intsel Chimos which was marketing finished dosage in France. The first European regulatory approval for oncology pain management and anti-emesis APi/formulation was likely to come through from France and Germany by April this year, he informed.

      Mr Hiremath said Hikal's Rs.25 crore new contract research facility near Pune would go on stream by the end of 2006. The facility would have 25 scientists initially for contract research for pharma, biotech, agro and speciality chemical companies and the number would reach 250 scientists finally, he added.

      January 24, 2006


      Share this Article!

    Back to top^